Vertex Pharmaceuticals, Inc.

+1.28 (+0.64%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)52.52B
Current PE19.01
Forward PE 16.68
2yr Forward PE 15.54
See more stats
Estimates Current Quarter
Revenue$1.83 Billion
Adjusted EPS$3.02
See more estimates
10-Day MA$200.20
50-Day MA$200.82
200-Day MA$215.15
See more pivots

Vertex Pharmaceuticals, Inc. Stock, NASDAQ:VRTX

50 Northern Avenue, Boston, Massachusetts 02210
United States of America
Phone: +1.617.341.6100
Number of Employees: 3400


Vertex Pharmaceuticals, Inc. is a global biotechnology company. It engages in the business of discovering, developing, manufacturing and commercializing small molecule drugs for patients with serious diseases. The firm focuses on development and commercializing therapies for the treatment of cystic fibrosis, infectious diseases including viral infections such as influenza and bacterial infections, autoimmune diseases such as rheumatoid arthritis, cancer, inflammatory bowel disease and neurological disorders including pain and multiple sclerosis. The company was founded by Joshua S. Boger in 1989 and is headquartered in Boston, MA.